Target Trial Emulation Favors Rituximab’s Effectiveness Over Cladribine in Treating Multiple Sclerosis
Written by
Neurology Live
Published
0
comments
0
min
A new study reveals rituximab outperforms cladribine in managing MRI disease activity in relapsing multiple sclerosis over 4.5 years.